Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, it’s okay. Bid-sitters Serve as support while others buy and watch their investment go up in value.
Tomorrow should be fun!
You bet! And there it is. Those 30mil biding 9s missed out on the 10s.
Moving up!
Over the last three trading days, including today’s trading, we have rotated through 403,893,270 shares. That’s POST last run.
The unrestricted O/S is: 375,652,447
I know everyone sees it. It’s ready to go up! IMO.
I like that accumulation, RSI, and MACD are all reversing and turning up! It’s not going to go down again. We are bottomed. Some see it some don’t. That’s okay. We all know charts don’t go vertical. But hey, I have to be in it to win it!
IMO
Go GHHC $$$$$$$$$$$
They’ve all got the finger on the buy button. Case in point: look at the action earlier when I bought 20mil shares (9&10s). They had no problem hitting the ask at 10,11,&12.
This will move up easy. It’s a matter who comes to realization that they could have had those 10s but somebody (not on the bid) swoops in and buys them. IMO. Happened before............
Completely understand and agree.
All my best!
Big company. I can see it know; distribution partnership or a controlling stake. Either way nobody likes loosing market share.
You don’t play in the big boys sandbox without them getting involved. Up front or directing from behind. IMO
PR says “More updates coming soon.”
I have to consider the implied meaning behind this statement:
“We are being contacted by senior executives and industry professionals from a variety of countries, even beyond Europe."
These guys seem very excited about the future of the company.imo
MIAMI, FL / ACCESSWIRE / September 10, 2019 / GH Capital, Inc. (OTC PINK:GHHC), a diversified holding company, is pleased to announce that its Vitana-X subsidiary, a comprehensive health and wellness network marketing program, has started its European pre-launch with great success having received registrations from 19 different countries already in its first 24 hours.
Vitana-X Chief Operating Officer and Strong Man strength athlete Matthias Goeth, commented, "This is just the beginning as much more is to come. Our entire team is very excited about the successful start! We are being contacted by senior executives and industry professionals from a variety of countries, even beyond Europe."
Vitana-X offers comprehensive programs for greater well-being, fitness and health by helping customers achieve the desired fitness and health results and offering exercises that fit your body type. Vitana-X wants to support people in their healthy development and be their reliable partner for their full potential.
Vitana-Xs marketing plan utilizes the most proven and effective form of marketing, recommendations. The Company rewards its satisfied customers as soon as they recommend the products to their friends or family.
More updates coming soon.
AGREED 100%!
If I saw a new product taking my market share, and it’s a great product, I’d look at how I’m going to get control of it.
Well well we’ll look at all those BUYS!
Yes, Sir! There’s nothing wrong with the Company’s model. What a giant leap into the energy drink market!
I think back to when monster hit the shelves. I thought this will never amount to anything. MAN WAS I SOOOO WRONG!
Now I’ve got another shot and I love the branding and marketing taking place with Vitana-X!
Go GHHC $$$$$$$$$$$$$
Well, I hit it as hard as could and the ask went from 23mil down to 17mil. WITH NO RE STACKING. So, I’ve validated, to my satisfaction, that what’s on the ask IS ALL THATS AVAILABLE at that price. Just my opinion.
Happy I got allot of 9s also to pull my average down.
I’m reset, let’s go GHHC!!!!!
Good morning splintered sunlight,
Here are the answers to your questions:
Is $JETR still heavily shorted?
No. But still being shorted. Reference: https://otcshortreport.com/company/JETR
Are the shorts still in a pickle now because the company indeed is doing very well.
Yes, IMO they are in a pickle
Are there are only 19mil OS and the float is probably less than 3 mil?
Per the latest 10q and the otc update; nothing has changed. Reference: https://www.otcmarkets.com/stock/JETR/security
Are you still holding your shares as the MMs play games?
No. I sustained heavy losses. Looking for a re-entry.
In the end, the share price should skyrocket! - Do you still feel that way?
Yes, I feel the low combination of little exposure and very low volume is a perfect storm for people to short any stock.
What will work against the shorts is the only 2mil float. When that shifts into strong hands everything changes.
I bought in around .15 so I didn’t control enough of the float to at least hold that price. My mistake.
Again, I’m looking for a re-entry point.
All my best,
E
Oh yea, it’s ready to break loose! Hitting 8s on 7mil vol. the 7s that we’re sold were a direct reduction in the available 8s. They got nothing left to hold it down!
Time to fly CBDL!!! This is going to be a fun ride up!!!!
What’s up beer$$money! Yea, I’m sure you saw it flash 44mil bid earlier. All those bids show up overnight. Hmmmmmm?
I can’t wait to see it break out!
Happy hunting Sir!
Thanks. I’ve been in and out of CBDL for awhile, but I’ve always liked the company. It’s solid for a small company. I can see a buyout or strategic partner in their future. They are building a good model and in a very lucrative sector. Imo
The shorts have really gone out on a limb here. The public float is extremely low. That’s why they couldn’t manage to push it any lower than 5. But that never stuck. It kept moving back to 7s. But they continued to short it.
Now there’s no shares available for them cover. They were trying so hard on Aug 31st. They shorted over 95% of the volume! And still couldn’t push it down! https://otcshortreport.com/company/CBDL
Going to be an unbelievable short squeeze! https://otcshortreport.com/company/CBDL
They didn’t count on me buying 30mil shares yesterday!
Float is only:
125,540,897
01/07/2020
37mil x 3mil.
Going Up!
Good morning all. Ran out of posts again yesterday.
I’m still waiting on Harry to email me back. Will report.
The fundamentals haven’t changed here. Looks like MM games. Blows but someone getting a great entry.
Go ENZC$$$$$
FOMO kicking in! Fillings and update coming literally anytime! Shorts getting caught without shares! I love the action!
Going Up ENZC$$$$$$$$$$$$
Gotcha Boss, you’re correct. 9s are much thinner.
Going UP!
Looks like a whole lotta BUYING AT THE ASK ALL DAY!
Going Up!!!!!!
Yes, we are the cusp of full throttle! Update coming end of August to first of September. Literally could drop at anytime as we are in the timeframe.
Peeps are accumulating but there’s just not many will to sell. I can’t wait for the breakout! The action here is going to be epic! IMO. Supper exciting setup! I love it!
“full destruction of the viruses”
“absolutely harmless”
We have tested ImmunH on volunteers and the medicine has shown that it is highly effective(for full destruction of the viruses) and is absolutely harmless. ImmunH can also be used to strengthen the immune system in people that are not infected with a virus, because it is a natural product.
https://www.immunotechlaboratoriesbg.com/
One good mainstream PR coverage and It’s $2.00 plus easy. It should be up there with with at least the phase II bios, AND WE ARE PHASE IV! PROVEN EFFECTIVE!
I’m definitely holding on tight. This is going to be fun ride up!
https://www.immunotechlaboratoriesbg.com/
MULTIPLE APPLICATIONS not JUST HIV. CANCER treatment being one of them! $$$$$$$$
"ImmunH" is the trade name of the medicine "ITV-1"
Welcome to Immunotech Laboratories BG,
We are a corporation, which is dedicated to the development of medicine for HIV-1 Infection, Chronic Infection, Hepatitis(A,B,C), Rheumatoid Arthritis, some types of Cancer and every other viruses connected with the immune system of the human being.
We have tested ImmunH on volunteers and the medicine has shown that it is highly effective(for full destruction of the viruses) and is absolutely harmless. ImmunH can also be used to strengthen the immune system in people that are not infected with a virus, because it is a natural product.
We have tested ImmunH on patients who suffered from HIV/AIDS in a clinical trial conducted under the strict guidelines of the European Union. The results of the clinical trial have shown:
improvement in the immune indices in the absolute number of Ly, CD3 T, CD4 T, CD8 T, B Ly, NK and in the percentage of CD3 T, CD4 T, CD8 T, B Ly, NK, and of the index CD4/CD8,
decrease in the viral load,
a good treatment effect on opportunistic infections,
very good compatibility with all of the other modern antiretroviral drugs,
very good tolerance in all patients and complete absence of side effects.
ImmunH is presented in the form of 16 injections, which are administrated biweekly on consecutive days for eight weeks using an intramuscular method. Before injection, the vial must be shaken and temperate to ambient temperature. One vial of the medicine contains 3 ml of the active compound per injection and must be stored in a surrounding with a temperature between +2°C to +8°C.
The medicine has a positive effect on the treatment of different kinds of cancer, as it stimulates the immune answer and strengthens the immune system of the human being.
"ImmunH" is the trade name of the medicine "ITV-1" .
https://www.immunotechlaboratoriesbg.com/
I JUST EMAILED HARRY. WILL REPORT BACK. I LIVE CLOSE TO THE NEW OFFICE IN PLANO, TX.
I’m confused about your post. It kinda negative for someone who bought in February. You should be very green right now with your 30 million shares. I hold 28mil.
GO ENZC $$$$$$$$$$$$$$$$$
ITV-1
Enzolytics, Inc.'s flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.
True and wise words Q7. The upside potential is enormous. I agree we are PROVEN vs. other bios trading much much higher that haven’t even begun trials.
It’s going to be a life changing stock for sure.
All my best and enjoy the vacation!
ITS ON LIKE DONKEY KONG!!!
Accumulation through the roof!!!
RSI @ 77 sweet!
MACD UP AND UP!
Money coming into ENZC
SHARES IN SHORT SUPPLY!!!
THANK YOU Q7 for your DD summation. I just reposted it. What a great read! Thanks again Q7.
DD GREAT SUMMATION Q7! MUST READ! KNOW WHAT YOU OWN! Sticky Please moderators
Credit post to: Q7
Tuesday, 08/25/20 10:31:05 AM
Re: onthefritz101 post# 94 0
Post # of 96
Potential biotech unicorn @.0005: ENZC.
Brief notes for da’ impatient mental patients out there lol: basically ENZC owns 49% of a Phase IV (yes, as in Phase III done ...something some $20 Naz biotechs dont have ..yes though this is in Eastern Europe but still approved testing by World Practice Show and under European Union strict guidelines ) ....antiviral drug that was shown to kill an incredible 80% of HIV in tests done. 80%. Stock is at lol .0005 ...what is going on? And now in April 8k we read company is trying to now produce it in labs here in U.S....get final approvals to sell in Eastern Europe and then everywhere else. So this is worth a starter at the very least i think cause this news could now hit anytime.....making it the cheapest by ten million miles Phase IV producing then selling major breakthrough antiviral drug public company.
Oh and here is then U.S. Patent too !:
https://www.lens.org/lens/patent/044-137-896-893-976/fulltext
..and it’s valued at over $5 million, which alone without use put the pps at MC of .0025:
https://enzolytics.com/patent
So you can stop there if you want cause thats all the facts and shows how extremely undervalued ENZC is. Below though you will see a decent to good SS for a biotech, especially one in lol Phase IV(!) and on verge of finally producing then selling their breakthrough antiviral drug thats now taken 15 years of research......and also THE reason why I post this NOW.....and why this may run yuuuuge soon: an iHub poster got an email supposedly claiming that the CEO is dropping news in next couple weeks after the lawyers get some things done. News doesnt come often here....so chart is near bottom...hasnt been a huge run in a long time: this biotech is Ready.
Now onto speculation and i think low hanging fruit and easy dots to connect what ALSO may be happening with ENZX and their novel antiviral ImmunH. Guys, these Phase I through III studies ALSO found that their ImmunH works very well with other kinds of viruses, is compatible w other antiviral medications....and is completely safe. wow. So what other kinds of viruses have happened in world since their 2017 Phase III very successful trial was passed and completed. well of course....Covid 19.
But first read up on it all to wrap your head around what could be coming. Again...definitely an awesome HIV treatment that ALONE w 80% kill rate and passed Phase III onto production.......warrants a pps in dimes w an OS under 2 bil wouldnt you think? ...but maybe something else too cause they developed the past 10 years something that by chance, is exactly what some of the rare and even NIH recommended Covid treatments are NOW using: ‘ Immune Modulators’ therapies. ...(right time right biotech breakthrough....right insanely cheap biotech trip z pps, with a SS like this....w tradeable float around a billion w the 738 mil Restricted shares....so real quick before go on the SS:
Authorized Shares
3,000,000,000
07/31/2020
Outstanding Shares
1,855,279,812
07/31/2020
Restricted
738,839,585
07/31/2020
Unrestricted
1,116,440,227
07/31/2020
..now read this from ENZC’s website:
Enzolytics currently holds a 49% Interest in Immunotech Laboratories BG-Europe. Immunotech BG-Europe has a license for the development and commercialization of Enzolytics Patented ITV-1 Technology. Immunotech BG-Europe , under the branded ImmunH , utilizing the technology has successfully completed Phase III clinical trials at the Specialized Hospital for Active Treatment of Infectious and Parasite Disease in Sofia, Bulgaria, specific for the treatment of HIV/AIDS.
MONROVIA, CA / ACCESSWIRE / January 25, 2017 / Immunotech Laboratories, Inc. announced today the completion of successful clinical Phase III testing on patients suffering from HIV/AIDS of its patented medical product, ITV-1-ImmunH treatment. The clinical trials were conducted through IMMB's subsidiary, Immunotech Laboratories BG – Europe ("IMMB-BG") at the Specialized Hospital for Active Treatment of Infectious and Parasite Diseases – "Prof. Ivan Kirov", Sofia Bulgaria. The trials, using the most current state of the art clinical testing methods available, which were approved at the World Practice Show, revealed significant positive results in treating the deadly disease. Data from the final report shows improvement in immune indices in the absolute number of LY, CD3 T, CD4 T, CD8 T, B Ly, NK levels and in the percentage of CD3 T, CD4 T, CD8 T, B Ly, NK and in the CD4/CD8 index. Most importantly, viral loads in approximately 80% of the blood samples of the patients, after completion of the treatment cycles, came back at non-detectable levels. Other important results noted in the summary report were the positive treatment effect on opportunistic infections, compatibility with all other antiviral drugs, high level of tolerance in all patients and the complete lack of any negative side effects.
The full report is available on the Company Website, www.immunotechlab.com. Additional information is available on the website of our subsidiary Immunotech Laboratories BG-Europe – www.immunh.com.
https://uk.finance.yahoo.com/news/immunotech-laboratories-inc-announces-successful-213000353.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAGN0tbGYr4m7Edw6mI3v1uIYFfa9PQuWfZQ8sfZbK7psPx1neGPYWJLOr-3S6wCwVVQ0RCLT8b3TnPxJ9m-6joA019ZUTQ2E4ryFRye3POpZoCeQ6Bkzyk40uzr-kbktvQAqpixnKgCVodS5uAGFRjjGOGNfIKBpGNnUy4zWKeBn
Welcome to Immunotech Laboratories BG,
We are a corporation, which is dedicated to the development of medicine for HIV-1 Infection, Chronic Infection, Hepatitis(A,B,C), Rheumatoid Arthritis, some types of Cancer and every other viruses connected with the immune system of the human being.
We have tested ImmunH on volunteers and the medicine has shown that it is highly effective(for full destruction of the viruses) and is absolutely harmless. ImmunH can also be used to strengthen the immune system in people that are not infected with a virus, because it is a natural product.
We have tested ImmunH on patients who suffered from HIV/AIDS in a clinical trial conducted under the strict guidelines of the European Union. The results of the clinical trial have shown:
* improvement in the immune indices in the absolute number of Ly, CD3 T, CD4 T, CD8 T, B Ly, NK and in the percentage of CD3 T, CD4 T, CD8 T, B Ly, NK, and of the index CD4/CD8,
* decrease in the viral load,
* a good treatment effect on opportunistic infections,
* very good compatibility with all of the other modern antiretroviral drugs,
* very good tolerance in all patients and complete absence of side effects.
https://www.immunotechlaboratoriesbg.com
ImmunoTech Laboratories BG-Europe has filed for a mass use permit, Phase IV, in Bulgaria. Enzolytics is seeking a Contract Manufacturing Organization (CMO) in the United States to produce the Immunotherapy Treatment to be used as the validation batch in coordination with the Bulgarian regulatory authority and Immunotech BG-Europe.
Additionally, ImmunoTech BG-Europe has informed Enzolytics that they will be seeking to register the ImmunH product as a ImmuneModulator, allowing use as an adjunct in additional applications to regulate or normalize the Immune System.
https://enzolytics.com/immunh-bg%2Feurope
...so,guys.....Immune Modulators. Hmm. Why would BG-Europe inform ENZC that they WILL BE seeking to register ImmunH as an ‘Immune Modulator’? Could it have anything to do with, the NIH in June actually green-lighting an Immune Modulator, ‘dexamethasone’ as one of the rare actual therapies that has been shown to work...out of so many now tried?...yes the below is from the U.S. ...NIH!:
Immunomodulators Under Evaluation for the Treatment of COVID-19
Last Updated: July 30, 2020
Summary Recommendations
Dexamethasone
• On the basis of the preliminary report from the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial, the Panel recommends using dexamethasone 6 mg per day for up to 10 days for the treatment of COVID-19 in patients who are mechanically ventilated (AI) and in patients who require supplemental oxygen but who are not mechanically ventilated (BI)
https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/
“Dexamethasone reduces mortality by one-third in ventilated patients with COVID-19”
https://www.healio.com/news/pulmonology/20200616/dexamethasone-reduces-mortality-by-onethird-in-ventilated-patients-with-covid19
.“ By contrast, the use of interleukin-6 (IL-6) inhibition might have benefits by controlling the pathological immune response to the virus. Here, we expand on the theoretical basis of IL-6 inhibition and propose potential benefits from other immunomodulators that could, in theory, prove more efficacious.“
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30226-5/fulltext
“The exact cause of the lymphopenia is not clearly understood, and SARS-CoV-2 is not known to productively infect T-lymphocytes. However, the lymphopenia could possibly explain why some cytokines, such as IL-6 tend to reduce with increased severity of disease.
Given the complex nature of the immune response with COVID-19, there is little surprise that a diverse group of immunomodulators are being evaluated in clinical trials. We highlight many of them here.“
https://cellculturedish.com/covid-19-therapeutics-in-clinical-trials-the-immunomodulators/
.....And again.....ENZC and BG know that their ImmunH not only kills HIV so effectively, it discovered that it did a great job w other viral infections w no side effects. So on their last 8k...see company description:
“Enzolytics is committed to the betterment of health for all mankind and exploring/developing additional applications of its novel immunotherapy compounds to that end.”
https://www.otcmarkets.com/filing/html?id=14076248&guid=Y24HUK4N_tD88th
....finally and sorry for length....but a scam fake news article came out about ENZC in Feb about some kind of ENZC Covid treatment which company immediately denied.......but the scammers at that time used the fact that early on scientists knew HIV drugs could possibly help Covid and looked most promising ...which STILL in fact makes ENZC very compelling..........but those scammers did not know about ENZC’s ImmuneModulator aspect and how the NIH in June would allow one to be officially used on the Covid fight. So in the end ENZC has almost a literal cure for HIV.....and signaling i think to market that they are going to also join the Covid fight as they claim that ImmunH does so well w no side effects against other viruses too.
....and finally finally etc: its also a big deal cause brtxq which ran from .0004 to now over a penny ....is running cause yes perhaps shares will not be wiped out...but also cause its has its own clinical trials, but they are in Phase II......ENZC completed Phase III two years ago is now onto Phase IV final approvals the production and sales. Or take SOAN they just got only the license to one day treat MS patients....from an Italian company.....not even Phase I done yet this process will take years and years yet pps going crazy.....: ENZC has a literal Phase IV all steps completed antiviral HIV 80% killer drug ready to soon go to market...millions of miles ahead of SOAN.
Again...ENZC is severely underpriced at .0005 .....
So in end starter position anything below .001 w all the above for me is no brainer. Nothing in market can run like a novel biotech. And ENZC has near cure for HIV and i think worth a shot at Covid. All this and if this iHub poster is telling truth, updates coming in next couple weeks:
MAGA_PATRIOT Monday, 08/24/20 02:35:37 PM
Re: The Penny Oracle post# 19435
0.001
Post # 19439 of 19449
Hey Penny and rest of ENZC'ers- New to this board, but jumped in ENZC at the beginning of the year. I called Harry a couple of weeks ago and left him a voicemail. He called me back later that same evening, and I spoke with him for 10-15 min. He did say that we would have an update towards the end of the month (August) and/or very beginning of September, and more importantly said that:
"we are just waiting for the lawyers to finish up and give us the OK to proceed."
He did not elaborate on what the lawyers are working on, etc..., but I did find it interesting. Could be the SEC lawyers that they said they retained to get current, or it could be something much bigger/better. Either way, I interpreted it as though we'd have a pretty substantial updated by early September.
Okay, when you quote the patent why don’t include the full statement. Your post makes the unwitting think “no value”. HERE IS THE REAL STATEMENT: “Patent Title:
Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising the same for detecting, preventing, and treating HIV.”
https://enzolytics.com/patent
PATENT VALUE PROJECTED MARKET SIZE
Estimated Size of Patent Protected Market: $10,493,259.32
PATENT VALUE PROJECTED PATENT VALUATION Predicted Patent Value: $5,203,874.67
PATENT VALUE LEGAL SUMMARY Remaining Life of Patent: 15 Years 6 Months
Good morning ENZC! Good morning Waterpro42, sorry I couldn’t reply yesterday. Used up my posts. I agree, we are all good here.
ENZC has been shorted heavily ( https://otcshortreport.com/company/ENZC ) and the uptick in negative posters shows me that they are worried! And they should be! Yesterday’s easy movement up gave me the validation that THE ONLY SHARES AVAILABLE ARE WHATS ON THE ASK. WHEN THERE GONE, THEY ARE GONE. That makes for a massive short squeeze, IMO!
It’s pretty obvious when they sell short into the bid and the ASK DOESN’T CHANGE. I will not be duped into fear selling because I’d just have to buy my shares back at the higher ASK. IMO.
Aug 26 Volume 148,823,932
Short Volume 87,266,929
% of Vol Shorted 58.64
We had a very good accumulation day. I’m betting not your average traders. This company, although behind in fillings (FILLINGS COMING SOON ) is about to start mass production of a phase IV proven drug treatment for HIV. Not to mention it has multiple applications to treat VIRUSES. I’m betting the obvious (COVID-19). It is an interesting twist that the mass production will be done here in the USA first. All on the company website.
Obvious shorting. ASK Remains high.
15 plus years remaining on the patent. Not a one trick pony either. Multiple uses: “the compound holds promise for several infectious diseases, chronic infections and hepatitis for which enhanced cell-mediated immunity would be beneficial.”
Info on our Patent: ITV-1 – ImmunH is a drug compound for treatment HIV-1 infection AIDS and Hepatitis . However, based on preclinical binding data, anecdotal clinical data, and early results from the South African immunology studies indicating an apparent Th1 immune mechanism, the compound holds promise for several infectious diseases, chronic infections and hepatitis for which enhanced cell-mediated immunity would be beneficial.
DOSAGE AND ADMINISTRATION
ITV-1 – ImmunH is presented in the form of 16 injections, which are administrated biweekly on consecutive days for eight weeks using an intramuscular method. Before injection, the vial must be shaken and temperate to ambient temperature.
CONTRAINDICATIONS AND DRUG INTERACTIONS
ITV-1 – ImmunH can not be used with other vaccines or other protein containing treatments.
ITV-1 – ImmunH can not be used in parallel with any immunosuppresive drugs.
SIDE EFFECTS AND OVER DOSAGE
Some patients have demonstrated mild flue like symptoms with occasional low-grade fever, malaise and arthralgias.
Animal safety studies have demonstrated no toxic effects.
At testing on people in a clinical trial of 32 injections on each patient, has been shown: complete lack of side effects, good tolerance in all patients, improvement of the immune status, decrease in the viral load, a good treatment effect on opportunistic infections, very good compatibility with all of the other modern antiretroviral drugs.
ITV-1 – ImmunH appear to be safe and does not impair the ability of people to operate machinery.
Nobody selling. Got to pay to play! Going up!
Sweet! 8s up! Going up!
Okay, 7 mo. That put your buy at Feb. 3rd. Assuming your down. Otherwise, any buys the rest of February puts you in the green.
You could have got out in April and definitely in July, but you still own it. Come on, We are here to make money!
Just look at the support. Anyone watching the action today can see that it all buys. What’s on the ASK is all there is. Just got to hit it.
Good luck to ya.
I see this as a SUPPLY AND DEMAND. And right now the shares are in short supply and demand is obviously high.
Sorry you sold all your 5 and 6s to me this morning. Just business. I’d get a new position and ride it up.
Going up.